Search press releases
Every release here is real and links to its original. Filter by company, topic, language and date.
- Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents with C3G or Primary IC-MPGNCompanies: BiogenBiogen Inc. (Nasdaq: BIIB) today announced the publication of results from a prespecified adolescent subgroup analysis of the Phase 3 VALIANT study evaluating EMPAVELI® (pegcetacoplan) in the Clinical Journal of the American Society of Nephrology (CJASN). The dedicated subgroup analysis was first presented at the 2025 Annual Meeting of the European Society of Paediatric Nephrology (ESPN).
- Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)Companies: Biogen–4-year data from the Phase 1/2a open-label extension (OLE) studies showed substantial and durable reductions in seizures and continuing improvements in cognition and behavior in patients treated with zorevunersen on top of standard of care anti-seizure medicines–
- Biogen entscheidet sich für Veeva Vault CRMCompanies: BiogenVeeva SystemsEine einheitliche Handelsplattform, die dazu beiträgt, die Lieferung von Medikamenten an Patienten zu beschleunigen PLEASANTON, Kalifornien, 26. August 2026 -- Veeva Systems (NYSE: VEEV) gab heute bekannt, dass sich Biogen weltweit für Veeva Vault CRM entschieden hat. „Es ist...